Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

India’s Pricing Tussle Escalates After Regulator Names “Overcharging” Firms

Apr 12 2017

• By Anju Ghangurde

Fig

Related Content

Fosun On Course To Full Indian Clearance For Gland Buyout

Mar 31 2017

India's Stent Price Slash Creating Climate Of Fear, Foreign Device-Makers Say

Mar 15 2017

Regulators And Pharma Lock Horns On Pricing In India

Sep 01 2016

Related Companies

Sun Pharmaceutical Industries Ltd.

Dr. Reddy's Laboratories Ltd.

Cipla Limited

GSK plc

Additional Topics

India Asia Pacific Policy Pricing Debate BioPharmaceutical

More from India

More from Asia

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.